Kathleen Skarvan Sells 38,954 Shares of Electromed, Inc. (NYSE:ELMD) Stock

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 38,954 shares of Electromed stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $29.28, for a total value of $1,140,573.12. Following the transaction, the director now directly owns 32,622 shares of the company’s stock, valued at approximately $955,172.16. This represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Kathleen Skarvan also recently made the following trade(s):

• On Friday, February 14th, Kathleen Skarvan sold 8,640 shares of Electromed stock. The shares were sold at an average price of $32.25, for a total value of $278,640.00.

Electromed Stock Performance

Shares of ELMD stock traded down $0.19 during mid-day trading on Wednesday, reaching $29.36. 96,902 shares of the company were exchanged, compared to its average volume of 107,469. The company has a market capitalization of $251.32 million, a P/E ratio of 39.15 and a beta of 0.33. Electromed, Inc. has a fifty-two week low of $13.74 and a fifty-two week high of $35.56. The business’s 50 day simple moving average is $31.40 and its 200 day simple moving average is $25.15.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of Electromed from a “strong-buy” rating to a “buy” rating in a report on Wednesday.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. bought a new stake in shares of Electromed during the 4th quarter worth about $37,000. IFP Advisors Inc acquired a new position in shares of Electromed in the fourth quarter worth about $59,000. Quantbot Technologies LP purchased a new position in Electromed during the 4th quarter worth approximately $99,000. Bank of America Corp DE boosted its position in Electromed by 179.2% during the 4th quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock worth $118,000 after acquiring an additional 2,570 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Electromed during the 4th quarter valued at $119,000. Institutional investors and hedge funds own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.